Nidderau, Germany

Erhard Seiller

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 1994-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Erhard Seiller: Innovator in Pharmaceutical Solutions

Introduction

Erhard Seiller is a notable inventor based in Nidderau, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inner ear disorders. With a total of four patents to his name, Seiller's work focuses on innovative drug formulations and delivery systems.

Latest Patents

One of Seiller's latest patents is a titration package for neramexane and its use in treating an inner ear disorder. This invention relates to a titration scheme that allows for the quick attainment of an effective dose while minimizing side effects. The titration package provides neramexane or its pharmaceutically acceptable salts in at least two different dosages, which may be beneficial in treating various diseases, including tinnitus. Another significant patent involves immediate release formulations of 1-aminocyclohexane compounds, specifically memantine and neramexane. This invention describes an immediate release solid oral dosage form that exhibits dose proportionality and is released at a dissolution rate of over 80% within the first 60 minutes of administration. The formulation is designed for once-daily or twice-daily dosing while maintaining a steady average range of therapeutic effect.

Career Highlights

Throughout his career, Erhard Seiller has worked with prominent companies in the pharmaceutical industry, including Merz & Co. and Merz Pharma GmbH & Co. KGaA. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and delivery.

Collaborations

Seiller has collaborated with notable colleagues such as Eberhard Nurnberg and Stefan Ritsert. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Erhard Seiller's contributions to pharmaceutical innovations demonstrate his commitment to improving treatment options for patients with inner ear disorders. His patents reflect a deep understanding of drug formulation and the importance of effective dosing strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…